Germany-wide personalised medicine study for high-risk paediatric cancer patients.
•
Comprehensive sequencing and analysis is feasible in clinically relevant time frame.
•
Half of patients across entities harbored a reasonable confidence druggable target.
•
Cases of clinical response to targeted agents demonstrate proof of principle.
•
This model can expand paediatric access to molecular profiling and targeted therapies.
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.